In ccRCC, loss-of-function mutations in the von Hippel-Lindau (VHL) gene, present in approximately 95% of cases, lead to constitutive activation of HIF-1α and subsequent CAIX upregulation [51]. The gene discussed is CA9; the disease is nonpapillary renal cell carcinoma.